Cargando…
ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003
BACKGROUND: ND630 is believed to be a new therapy pharmacologic molecule in targeting the expression of ACACA and regulating the lipid metabolism. However, the function of ND630 in prostate cancer remains unknown. KIF18B, as an oncogene, plays a vital role in prostate cancer progression. circKIF18B_...
Autores principales: | Wu, Yu-Peng, Zheng, Wen-Cai, Huang, Qi, Huang, Xu-Yun, Lin, Fei, Ke, Zhi-Bin, You, Qi, Zheng, Qing-Shui, Wei, Yong, Xue, Xue-Yi, Xu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694902/ http://dx.doi.org/10.1186/s12967-023-04760-w |
Ejemplares similares
-
CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
por: Luo, Kui, et al.
Publicado: (2022) -
circKIF4A sponges miR-127 to promote ovarian cancer progression
por: Sheng, Shunliang, et al.
Publicado: (2020) -
Oxidative stress-induced circKIF18A downregulation impairs MCM7-mediated anti-senescence in intervertebral disc degeneration
por: Wang, Jianle, et al.
Publicado: (2022) -
CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer/T-Cell Lymphoma Progression
por: He, Rongfang, et al.
Publicado: (2022) -
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)